Publication:
EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis

Simple item page
dc.contributor.authorPalacios, Santiago (7006012524)
dc.contributor.authorBrincat, Mark (57035684300)
dc.contributor.authorErel, C. Tamer (35931912800)
dc.contributor.authorGambacciani, Marco (7004392662)
dc.contributor.authorLambrinoudaki, Irene (6601969370)
dc.contributor.authorMoen, Mette H. (7006480484)
dc.contributor.authorSchenck-Gustafsson, Karin (7004633272)
dc.contributor.authorTremollieres, Florence (35497234700)
dc.contributor.authorVujovic, Svetlana (57225380338)
dc.contributor.authorRees, Margaret (25936659300)
dc.contributor.authorRozenberg, Serge (8636087600)
dc.date.accessioned2025-07-02T12:40:47Z
dc.date.available2025-07-02T12:40:47Z
dc.date.issued2012
dc.description.abstractOsteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women. © 2011 Elsevier Ireland Ltd.
dc.identifier.urihttps://doi.org/10.1016/j.maturitas.2011.11.010
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84855812729&doi=10.1016%2fj.maturitas.2011.11.010&partnerID=40&md5=0a1450c3989ca3485ec8adef2da33795
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/13992
dc.subjectBazedoxifene
dc.subjectLasofoxifene
dc.subjectPostmenopausal osteoporosis
dc.subjectRaloxifene
dc.subjectSelective estrogen receptor modulators
dc.subjectTamoxifen
dc.titleEMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis
dspace.entity.typePublication

Files

Collections

Publikacije / Publications